The Now What To help companies understand shifting consumer behavior better, BCG has identified four archetypes of GLP-1 users: 41% are lifestyle optimizers who build broader wellness habits around their GLP-1s
Take the first step towards achieving a healthy weight and improving your wellness by scheduling a consultation at our clinic today
Better outcomes with GLP-1s in those with diabetes and peripheral arterial disease July 29, 2026 Summary: In a propensity-matched observational study of 2,133 pairs of patients with type 2 diabetes and peripheral artery disease, those prescribed GLP-1 receptor agonists had lower five-year rates of death, hospitalization, revascularization, and amputation than those prescribed metformin
Tirzepatide/L-Carnitine has been shown in clinical trials to be one of the fastest, most trustworthy ways to to help people lose an average of up to 25% of their initial body weight safely when combined with a reduced-calorie diet and increased physical activity
Kansanen et al., 2013) together with the upstream mediators (dead receptors